Details for New Drug Application (NDA): 012248
✉ Email this page to a colleague
NDA 012248 describes PLEGINE, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the PLEGINE profile page.
The generic ingredient in PLEGINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
The generic ingredient in PLEGINE is phendimetrazine tartrate. There are five drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.
Summary for 012248
| Tradename: | PLEGINE |
| Applicant: | Wyeth Ayerst |
| Ingredient: | phendimetrazine tartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 35MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
